UPHL — Uphealth Income Statement
0.000.00%
Last trade - 00:00- $0.00m
- $148.21m
- $130.00m
- 33
- 92
- 28
- 50
Annual income statement for Uphealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 5.4 | 124 | 159 | 130 |
| Cost of Revenue | ||||
| Gross Profit | 4.21 | 42.5 | 63.7 | 65.9 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 7.32 | 504 | 373 | 161 |
| Operating Profit | -1.93 | -380 | -214 | -30.5 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -2.06 | -343 | -232 | -57.6 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -2.11 | -340 | -223 | -56.4 |
| Minority Interest | ||||
| Equity in Affiliates | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -2.19 | -341 | -223 | -57.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -2.19 | -341 | -223 | -57.8 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.186 | -85.4 | -6.83 | -1.97 |